304 AKI Flashcards
Common causes of community acquired AKI
Volume depletion Heart failure Adverse effect of medications Obstruction of urinary tract Malignancy
MOA VH
Common causes of hospital acquired AKI
Sepsis
Major surgery
Critical illness involving heart and liver
Nephrotoxic medication
SM CN
SM City
Common conditions associated with pre renal azotemia
Hypovolemia
Decreased cardiac output
NSAIDs
Inhibitors of angiotensin II
HINDe
When does renal auto regulation occur
SBP falls below 80 mmHg
Effect of NSAIDs on kidney
Renal afferent vasodilation
Effect of ACE-I and ARBs to kidney
Rena efferent vasoconstriction
Most common causes of intrinsic AKI
Sepsis
Ischemia
Nephrotoxin
SIN
Type 1 hepatorenal syndrome
SCr increase 2x or more than 2.5 mg/dl within 2 weeks despite volume administration and withholding diuretics
Very metabolically active part of nephron and most hypoxic region
S3 segment of proximal tubule
Most common cause of post renal AKI
Bladder neck obstruction
Laboratory feature of prerenal azotemia
BUN crea ratio more than 20 FeNa less than 1 Urine osomolality more than 500 mOsm/kg Hyaline cast Urine sp gravity more than 1. 018
Contrast nephropathy. Rise in SCr? Peaks and recovers?
Increase in SCr within 1-2 days
Peaks on 3-5 days
Resolves within 7 days
Laboratory findings show hypocomplementemia and eosinophiluria. Other causes of eosinophiluria
Atheroembolic disease (with hypocomplementemia) Allergic interstitial nephritis Pyelonephritis Cystitis Glomerulonephritis
Causes. Urinary sediments. Granular casts
ATN
GN
Vasculitis
Tubulointerstitial nephritis
Urinary sediments in acute cellular allograft rejection
Renal tubular epithelial (RTE) cells
RTE cast
Pigmented cast
Novel biomaker associated with ischemia. Type 1 transmembrane protein expressed in proximal tubule
Kidney injury molecule 1 (KIM-1)
Novel biomaker detected in plasma and urine 2 hrs of CABG
Neutrophils gelatinase associated lipocalin (NGAL)
Novel biomaker for risk of AKI among critically ill patients
Insulin growth factor binding protein 7 (IGFBP7)
Tissue inhibitor of metalloproteinase 2 (TMP-2)
Hallmark of AKI
BUN more than 100 mg/dl
Electrolyte abnormalities in AKI
Hyponatremia Hypocalcemia Hyperkalemia Hyperphosphatemia Hyperuricemia Hypermagnesemia Metabolic acidosis
Total energy intake in AKI
20-30 kcal/kg per day
Protein intake in AKI. Not on dialysis. On dialysis
Not on dialysis: 0.8-1.0 g/kg
On dialysis: 1.0-1.5 g/kg
Most common form of renal replacement therapy for AKI
Hemodialysis
When does AKI in burn patients occur
10% BSA
Antibiotics commonly associated with AKI
Aminoglycosides
Amphotericin B
Electrolyte imbalance in AKI
Hyperkalemia
Hyperphosphatemia
Hypocalcemia
Procedures commonly associated with AKI
Cardiac surgery with cardiopulmonary bypass
Vascular procedure with aortic cross clamping
Intraoperitoneal procedurez
Common risk factors for postoperative AKI
CKD Older age Diabetes Mellitus CHF Emergency procedures